Project
Mucociliary differentiation, bronchial epithelial cells, human (Ross 2007)
Navigation
Downloads
Results for HIC2
Z-value: 1.50
Motif logo
Transcription factors associated with HIC2
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
HIC2
|
ENSG00000169635.5 | HIC ZBTB transcriptional repressor 2 |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| HIC2 | hg19_v2_chr22_+_21771656_21771693 | 0.32 | 8.3e-02 | Click! |
Activity profile of HIC2 motif
Sorted Z-values of HIC2 motif
| Promoter | Log-likelihood | Transcript | Gene | Gene Info |
|---|---|---|---|---|
| chr19_-_51487282 | 5.54 |
ENST00000595820.1
ENST00000597707.1 ENST00000336317.4 |
KLK7
|
kallikrein-related peptidase 7 |
| chr15_+_90728145 | 4.13 |
ENST00000561085.1
ENST00000379122.3 ENST00000332496.6 |
SEMA4B
|
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4B |
| chr4_+_4388805 | 3.64 |
ENST00000504171.1
|
NSG1
|
Homo sapiens neuron specific gene family member 1 (NSG1), transcript variant 3, mRNA. |
| chr1_+_32042131 | 3.25 |
ENST00000271064.7
ENST00000537531.1 |
TINAGL1
|
tubulointerstitial nephritis antigen-like 1 |
| chr1_+_17531614 | 3.15 |
ENST00000375471.4
|
PADI1
|
peptidyl arginine deiminase, type I |
| chr9_+_33750515 | 3.09 |
ENST00000361005.5
|
PRSS3
|
protease, serine, 3 |
| chr12_-_52845910 | 3.07 |
ENST00000252252.3
|
KRT6B
|
keratin 6B |
| chr1_+_32042105 | 3.03 |
ENST00000457433.2
ENST00000441210.2 |
TINAGL1
|
tubulointerstitial nephritis antigen-like 1 |
| chr22_-_20367797 | 2.87 |
ENST00000424787.2
|
GGTLC3
|
gamma-glutamyltransferase light chain 3 |
| chr19_-_51487071 | 2.82 |
ENST00000391807.1
ENST00000593904.1 |
KLK7
|
kallikrein-related peptidase 7 |
| chr1_+_152881014 | 2.81 |
ENST00000368764.3
ENST00000392667.2 |
IVL
|
involucrin |
| chr8_+_124194875 | 2.65 |
ENST00000522648.1
ENST00000276699.6 |
FAM83A
|
family with sequence similarity 83, member A |
| chr16_-_30122717 | 2.52 |
ENST00000566613.1
|
GDPD3
|
glycerophosphodiester phosphodiesterase domain containing 3 |
| chr4_-_175443788 | 2.50 |
ENST00000541923.1
|
HPGD
|
hydroxyprostaglandin dehydrogenase 15-(NAD) |
| chr5_+_96212185 | 2.49 |
ENST00000379904.4
|
ERAP2
|
endoplasmic reticulum aminopeptidase 2 |
| chr17_-_26903900 | 2.49 |
ENST00000395319.3
ENST00000581807.1 ENST00000584086.1 ENST00000395321.2 |
ALDOC
|
aldolase C, fructose-bisphosphate |
| chr5_-_139726181 | 2.49 |
ENST00000507104.1
ENST00000230990.6 |
HBEGF
|
heparin-binding EGF-like growth factor |
| chr6_+_151646800 | 2.48 |
ENST00000354675.6
|
AKAP12
|
A kinase (PRKA) anchor protein 12 |
| chr10_+_102106829 | 2.46 |
ENST00000370355.2
|
SCD
|
stearoyl-CoA desaturase (delta-9-desaturase) |
| chr17_-_39928106 | 2.41 |
ENST00000540235.1
|
JUP
|
junction plakoglobin |
| chr1_-_50489547 | 2.41 |
ENST00000371836.1
ENST00000371839.1 ENST00000371838.1 |
AGBL4
|
ATP/GTP binding protein-like 4 |
| chr22_+_30792980 | 2.41 |
ENST00000403484.1
ENST00000405717.3 ENST00000402592.3 |
SEC14L2
|
SEC14-like 2 (S. cerevisiae) |
| chr10_-_43762329 | 2.37 |
ENST00000395810.1
|
RASGEF1A
|
RasGEF domain family, member 1A |
| chr14_-_75422280 | 2.37 |
ENST00000238607.6
ENST00000553716.1 |
PGF
|
placental growth factor |
| chr1_+_150522222 | 2.34 |
ENST00000369039.5
|
ADAMTSL4
|
ADAMTS-like 4 |
| chr22_+_30792846 | 2.32 |
ENST00000312932.9
ENST00000428195.1 |
SEC14L2
|
SEC14-like 2 (S. cerevisiae) |
| chr20_+_30102231 | 2.31 |
ENST00000335574.5
ENST00000340852.5 ENST00000398174.3 ENST00000376127.3 ENST00000344042.5 |
HM13
|
histocompatibility (minor) 13 |
| chr10_-_5541525 | 2.29 |
ENST00000380332.3
|
CALML5
|
calmodulin-like 5 |
| chr1_-_205419053 | 2.28 |
ENST00000367154.1
|
LEMD1
|
LEM domain containing 1 |
| chr1_-_9189229 | 2.25 |
ENST00000377411.4
|
GPR157
|
G protein-coupled receptor 157 |
| chr14_-_64194745 | 2.25 |
ENST00000247225.6
|
SGPP1
|
sphingosine-1-phosphate phosphatase 1 |
| chr17_+_73717407 | 2.24 |
ENST00000579662.1
|
ITGB4
|
integrin, beta 4 |
| chr17_-_8059638 | 2.23 |
ENST00000584202.1
ENST00000354903.5 ENST00000577253.1 |
PER1
|
period circadian clock 1 |
| chr17_+_73717551 | 2.23 |
ENST00000450894.3
|
ITGB4
|
integrin, beta 4 |
| chr2_-_224903995 | 2.20 |
ENST00000409304.1
ENST00000454956.1 ENST00000258405.4 |
SERPINE2
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 2 |
| chrX_-_131623874 | 2.17 |
ENST00000436215.1
|
MBNL3
|
muscleblind-like splicing regulator 3 |
| chr10_+_5566916 | 2.13 |
ENST00000315238.1
|
CALML3
|
calmodulin-like 3 |
| chr9_+_131102925 | 2.08 |
ENST00000372870.1
ENST00000300456.4 |
SLC27A4
|
solute carrier family 27 (fatty acid transporter), member 4 |
| chr9_+_33750667 | 2.04 |
ENST00000457896.1
ENST00000342836.4 ENST00000429677.3 |
PRSS3
|
protease, serine, 3 |
| chr10_+_124221036 | 2.04 |
ENST00000368984.3
|
HTRA1
|
HtrA serine peptidase 1 |
| chr7_+_134212312 | 2.04 |
ENST00000359579.4
|
AKR1B10
|
aldo-keto reductase family 1, member B10 (aldose reductase) |
| chr1_+_20915409 | 2.02 |
ENST00000375071.3
|
CDA
|
cytidine deaminase |
| chr4_+_8201091 | 2.01 |
ENST00000382521.3
ENST00000245105.3 ENST00000457650.2 ENST00000539824.1 |
SH3TC1
|
SH3 domain and tetratricopeptide repeats 1 |
| chr1_+_10270863 | 2.00 |
ENST00000377093.4
ENST00000263934.6 |
KIF1B
|
kinesin family member 1B |
| chr22_+_38071615 | 1.99 |
ENST00000215909.5
|
LGALS1
|
lectin, galactoside-binding, soluble, 1 |
| chr17_+_4736627 | 1.98 |
ENST00000355280.6
ENST00000347992.7 |
MINK1
|
misshapen-like kinase 1 |
| chr1_+_153388993 | 1.98 |
ENST00000368729.4
|
S100A7A
|
S100 calcium binding protein A7A |
| chr2_-_235405168 | 1.96 |
ENST00000339728.3
|
ARL4C
|
ADP-ribosylation factor-like 4C |
| chr12_+_41086297 | 1.95 |
ENST00000551295.2
|
CNTN1
|
contactin 1 |
| chr11_+_118826999 | 1.94 |
ENST00000264031.2
|
UPK2
|
uroplakin 2 |
| chr20_-_43280325 | 1.92 |
ENST00000537820.1
|
ADA
|
adenosine deaminase |
| chr10_+_5454505 | 1.91 |
ENST00000355029.4
|
NET1
|
neuroepithelial cell transforming 1 |
| chr7_-_27135591 | 1.90 |
ENST00000343060.4
ENST00000355633.5 |
HOXA1
|
homeobox A1 |
| chrX_-_153599578 | 1.90 |
ENST00000360319.4
ENST00000344736.4 |
FLNA
|
filamin A, alpha |
| chr20_-_54967187 | 1.90 |
ENST00000422322.1
ENST00000371356.2 ENST00000451915.1 ENST00000347343.2 ENST00000395911.1 ENST00000395907.1 ENST00000441357.1 ENST00000456249.1 ENST00000420474.1 ENST00000395909.4 ENST00000395914.1 ENST00000312783.6 ENST00000395915.3 ENST00000395913.3 |
AURKA
|
aurora kinase A |
| chr21_-_47604318 | 1.89 |
ENST00000291672.5
ENST00000330205.6 |
SPATC1L
|
spermatogenesis and centriole associated 1-like |
| chr10_-_33625154 | 1.89 |
ENST00000265371.4
|
NRP1
|
neuropilin 1 |
| chr2_+_113875466 | 1.86 |
ENST00000361779.3
ENST00000259206.5 ENST00000354115.2 |
IL1RN
|
interleukin 1 receptor antagonist |
| chr2_-_1748214 | 1.85 |
ENST00000433670.1
ENST00000425171.1 ENST00000252804.4 |
PXDN
|
peroxidasin homolog (Drosophila) |
| chr16_-_87903079 | 1.85 |
ENST00000261622.4
|
SLC7A5
|
solute carrier family 7 (amino acid transporter light chain, L system), member 5 |
| chr3_-_48594248 | 1.83 |
ENST00000545984.1
ENST00000232375.3 ENST00000416568.1 ENST00000383734.2 ENST00000541519.1 ENST00000412035.1 |
PFKFB4
|
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 |
| chr17_+_1959369 | 1.83 |
ENST00000576444.1
ENST00000322941.3 |
HIC1
|
hypermethylated in cancer 1 |
| chr1_-_231175964 | 1.82 |
ENST00000366654.4
|
FAM89A
|
family with sequence similarity 89, member A |
| chr5_-_39270725 | 1.75 |
ENST00000512138.1
ENST00000512982.1 ENST00000540520.1 |
FYB
|
FYN binding protein |
| chr17_+_7942335 | 1.74 |
ENST00000380183.4
ENST00000572022.1 ENST00000380173.2 |
ALOX15B
|
arachidonate 15-lipoxygenase, type B |
| chr1_+_152975488 | 1.73 |
ENST00000542696.1
|
SPRR3
|
small proline-rich protein 3 |
| chr6_-_34524093 | 1.72 |
ENST00000544425.1
|
SPDEF
|
SAM pointed domain containing ETS transcription factor |
| chr2_-_31361543 | 1.71 |
ENST00000349752.5
|
GALNT14
|
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 14 (GalNAc-T14) |
| chr8_-_101661887 | 1.70 |
ENST00000311812.2
|
SNX31
|
sorting nexin 31 |
| chr11_-_2170786 | 1.69 |
ENST00000300632.5
|
IGF2
|
insulin-like growth factor 2 (somatomedin A) |
| chr12_+_53491220 | 1.69 |
ENST00000548547.1
ENST00000301464.3 |
IGFBP6
|
insulin-like growth factor binding protein 6 |
| chr22_+_33197683 | 1.68 |
ENST00000266085.6
|
TIMP3
|
TIMP metallopeptidase inhibitor 3 |
| chr3_-_48632593 | 1.67 |
ENST00000454817.1
ENST00000328333.8 |
COL7A1
|
collagen, type VII, alpha 1 |
| chr16_+_88704978 | 1.67 |
ENST00000244241.4
|
IL17C
|
interleukin 17C |
| chr15_-_74659978 | 1.67 |
ENST00000541301.1
ENST00000416978.1 ENST00000268053.6 |
CYP11A1
|
cytochrome P450, family 11, subfamily A, polypeptide 1 |
| chr18_+_21452964 | 1.66 |
ENST00000587184.1
|
LAMA3
|
laminin, alpha 3 |
| chr8_+_124194752 | 1.66 |
ENST00000318462.6
|
FAM83A
|
family with sequence similarity 83, member A |
| chr6_+_43739697 | 1.66 |
ENST00000230480.6
|
VEGFA
|
vascular endothelial growth factor A |
| chr11_-_111783595 | 1.65 |
ENST00000528628.1
|
CRYAB
|
crystallin, alpha B |
| chr9_-_139891165 | 1.65 |
ENST00000494426.1
|
CLIC3
|
chloride intracellular channel 3 |
| chr2_-_31360887 | 1.65 |
ENST00000420311.2
ENST00000356174.3 ENST00000324589.5 |
GALNT14
|
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 14 (GalNAc-T14) |
| chr7_+_116165038 | 1.64 |
ENST00000393470.1
|
CAV1
|
caveolin 1, caveolae protein, 22kDa |
| chr17_+_37821593 | 1.64 |
ENST00000578283.1
|
TCAP
|
titin-cap |
| chr11_-_66675371 | 1.62 |
ENST00000393955.2
|
PC
|
pyruvate carboxylase |
| chr11_-_2193025 | 1.62 |
ENST00000333684.5
ENST00000381178.1 ENST00000381175.1 ENST00000352909.3 |
TH
|
tyrosine hydroxylase |
| chrX_-_48328631 | 1.57 |
ENST00000429543.1
ENST00000317669.5 |
SLC38A5
|
solute carrier family 38, member 5 |
| chr3_-_50340996 | 1.57 |
ENST00000266031.4
ENST00000395143.2 ENST00000457214.2 ENST00000447605.2 ENST00000418723.1 ENST00000395144.2 |
HYAL1
|
hyaluronoglucosaminidase 1 |
| chr5_-_39203093 | 1.57 |
ENST00000515010.1
|
FYB
|
FYN binding protein |
| chr11_-_62323702 | 1.56 |
ENST00000530285.1
|
AHNAK
|
AHNAK nucleoprotein |
| chr4_+_75230853 | 1.55 |
ENST00000244869.2
|
EREG
|
epiregulin |
| chr11_-_62313090 | 1.54 |
ENST00000528508.1
ENST00000533365.1 |
AHNAK
|
AHNAK nucleoprotein |
| chr2_-_47142884 | 1.53 |
ENST00000409105.1
ENST00000409973.1 ENST00000409913.1 ENST00000319466.4 |
MCFD2
|
multiple coagulation factor deficiency 2 |
| chr11_+_129245796 | 1.52 |
ENST00000281437.4
|
BARX2
|
BARX homeobox 2 |
| chr6_-_34524049 | 1.52 |
ENST00000374037.3
|
SPDEF
|
SAM pointed domain containing ETS transcription factor |
| chr19_-_51017881 | 1.51 |
ENST00000601207.1
ENST00000598657.1 ENST00000376916.3 |
ASPDH
|
aspartate dehydrogenase domain containing |
| chr17_+_79990058 | 1.50 |
ENST00000584341.1
|
RAC3
|
ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3) |
| chr14_-_35183755 | 1.50 |
ENST00000555765.1
|
CFL2
|
cofilin 2 (muscle) |
| chr1_-_153363452 | 1.47 |
ENST00000368732.1
ENST00000368733.3 |
S100A8
|
S100 calcium binding protein A8 |
| chr17_+_73717516 | 1.47 |
ENST00000200181.3
ENST00000339591.3 |
ITGB4
|
integrin, beta 4 |
| chrX_-_38080077 | 1.45 |
ENST00000378533.3
ENST00000544439.1 ENST00000432886.2 ENST00000538295.1 |
SRPX
|
sushi-repeat containing protein, X-linked |
| chr11_-_2162468 | 1.45 |
ENST00000434045.2
|
IGF2
|
insulin-like growth factor 2 (somatomedin A) |
| chrX_-_48328551 | 1.45 |
ENST00000376876.3
|
SLC38A5
|
solute carrier family 38, member 5 |
| chr8_-_125740514 | 1.42 |
ENST00000325064.5
ENST00000518547.1 |
MTSS1
|
metastasis suppressor 1 |
| chr1_+_26606608 | 1.42 |
ENST00000319041.6
|
SH3BGRL3
|
SH3 domain binding glutamic acid-rich protein like 3 |
| chr17_+_39975455 | 1.42 |
ENST00000455106.1
|
FKBP10
|
FK506 binding protein 10, 65 kDa |
| chr16_-_55867146 | 1.41 |
ENST00000422046.2
|
CES1
|
carboxylesterase 1 |
| chr17_+_40704938 | 1.41 |
ENST00000225929.5
|
HSD17B1
|
hydroxysteroid (17-beta) dehydrogenase 1 |
| chr1_-_47655686 | 1.41 |
ENST00000294338.2
|
PDZK1IP1
|
PDZK1 interacting protein 1 |
| chr5_+_167181917 | 1.39 |
ENST00000519204.1
|
TENM2
|
teneurin transmembrane protein 2 |
| chr3_+_10206545 | 1.38 |
ENST00000256458.4
|
IRAK2
|
interleukin-1 receptor-associated kinase 2 |
| chr18_-_31802056 | 1.38 |
ENST00000538587.1
|
NOL4
|
nucleolar protein 4 |
| chr19_+_41725088 | 1.37 |
ENST00000301178.4
|
AXL
|
AXL receptor tyrosine kinase |
| chr6_+_74405804 | 1.36 |
ENST00000287097.5
|
CD109
|
CD109 molecule |
| chrX_-_71351678 | 1.36 |
ENST00000609883.1
ENST00000545866.1 |
RGAG4
|
retrotransposon gag domain containing 4 |
| chr4_-_8073705 | 1.35 |
ENST00000514025.1
|
ABLIM2
|
actin binding LIM protein family, member 2 |
| chr9_+_132099158 | 1.35 |
ENST00000444125.1
|
RP11-65J3.1
|
RP11-65J3.1 |
| chrX_-_131623982 | 1.35 |
ENST00000370844.1
|
MBNL3
|
muscleblind-like splicing regulator 3 |
| chr6_-_30712313 | 1.34 |
ENST00000376377.2
ENST00000259874.5 |
IER3
|
immediate early response 3 |
| chr19_-_51522955 | 1.34 |
ENST00000358789.3
|
KLK10
|
kallikrein-related peptidase 10 |
| chr8_-_41522719 | 1.34 |
ENST00000335651.6
|
ANK1
|
ankyrin 1, erythrocytic |
| chr3_-_52567792 | 1.33 |
ENST00000307092.4
ENST00000422318.2 ENST00000459839.1 |
NT5DC2
|
5'-nucleotidase domain containing 2 |
| chr11_-_66103932 | 1.33 |
ENST00000311320.4
|
RIN1
|
Ras and Rab interactor 1 |
| chr8_+_10530133 | 1.32 |
ENST00000304519.5
|
C8orf74
|
chromosome 8 open reading frame 74 |
| chr22_-_37640277 | 1.32 |
ENST00000401529.3
ENST00000249071.6 |
RAC2
|
ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2) |
| chr18_+_21269404 | 1.30 |
ENST00000313654.9
|
LAMA3
|
laminin, alpha 3 |
| chr2_+_95940186 | 1.30 |
ENST00000403131.2
ENST00000317668.4 ENST00000317620.9 |
PROM2
|
prominin 2 |
| chr22_-_20368028 | 1.29 |
ENST00000404912.1
|
GGTLC3
|
gamma-glutamyltransferase light chain 3 |
| chr12_-_95009837 | 1.29 |
ENST00000551457.1
|
TMCC3
|
transmembrane and coiled-coil domain family 3 |
| chr22_+_42949925 | 1.27 |
ENST00000327678.5
ENST00000340239.4 ENST00000407614.4 ENST00000335879.5 |
SERHL2
|
serine hydrolase-like 2 |
| chr8_-_144655141 | 1.26 |
ENST00000398882.3
|
MROH6
|
maestro heat-like repeat family member 6 |
| chr22_+_25003626 | 1.26 |
ENST00000451366.1
ENST00000406383.2 ENST00000428855.1 |
GGT1
|
gamma-glutamyltransferase 1 |
| chr1_-_6545502 | 1.25 |
ENST00000535355.1
|
PLEKHG5
|
pleckstrin homology domain containing, family G (with RhoGef domain) member 5 |
| chr3_+_52350335 | 1.25 |
ENST00000420323.2
|
DNAH1
|
dynein, axonemal, heavy chain 1 |
| chr6_+_160769300 | 1.25 |
ENST00000275300.2
|
SLC22A3
|
solute carrier family 22 (organic cation transporter), member 3 |
| chr1_+_24646002 | 1.24 |
ENST00000356046.2
|
GRHL3
|
grainyhead-like 3 (Drosophila) |
| chr10_-_17659234 | 1.24 |
ENST00000466335.1
|
PTPLA
|
protein tyrosine phosphatase-like (proline instead of catalytic arginine), member A |
| chr5_+_135385202 | 1.24 |
ENST00000514554.1
|
TGFBI
|
transforming growth factor, beta-induced, 68kDa |
| chr6_-_39290316 | 1.24 |
ENST00000425054.2
ENST00000373227.4 ENST00000373229.5 ENST00000437525.2 |
KCNK16
|
potassium channel, subfamily K, member 16 |
| chr3_+_136537911 | 1.23 |
ENST00000393079.3
|
SLC35G2
|
solute carrier family 35, member G2 |
| chr1_+_156830607 | 1.22 |
ENST00000368196.3
|
NTRK1
|
neurotrophic tyrosine kinase, receptor, type 1 |
| chr6_-_112080256 | 1.21 |
ENST00000462856.2
ENST00000229471.4 |
FYN
|
FYN oncogene related to SRC, FGR, YES |
| chr15_-_74504597 | 1.21 |
ENST00000416286.3
|
STRA6
|
stimulated by retinoic acid 6 |
| chr14_+_85996471 | 1.21 |
ENST00000330753.4
|
FLRT2
|
fibronectin leucine rich transmembrane protein 2 |
| chr3_+_100354442 | 1.20 |
ENST00000475887.1
|
GPR128
|
G protein-coupled receptor 128 |
| chr1_+_10057274 | 1.20 |
ENST00000294435.7
|
RBP7
|
retinol binding protein 7, cellular |
| chrX_+_68048803 | 1.20 |
ENST00000204961.4
|
EFNB1
|
ephrin-B1 |
| chr17_-_76870126 | 1.20 |
ENST00000586057.1
|
TIMP2
|
TIMP metallopeptidase inhibitor 2 |
| chr22_-_26961328 | 1.20 |
ENST00000398110.2
|
TPST2
|
tyrosylprotein sulfotransferase 2 |
| chr19_-_39264072 | 1.19 |
ENST00000599035.1
ENST00000378626.4 |
LGALS7
|
lectin, galactoside-binding, soluble, 7 |
| chr2_-_70780770 | 1.18 |
ENST00000444975.1
ENST00000445399.1 ENST00000418333.2 |
TGFA
|
transforming growth factor, alpha |
| chr15_-_74504560 | 1.18 |
ENST00000449139.2
|
STRA6
|
stimulated by retinoic acid 6 |
| chr1_-_152552980 | 1.18 |
ENST00000368787.3
|
LCE3D
|
late cornified envelope 3D |
| chr3_-_12800751 | 1.17 |
ENST00000435218.2
ENST00000435575.1 |
TMEM40
|
transmembrane protein 40 |
| chr17_-_34122596 | 1.17 |
ENST00000250144.8
|
MMP28
|
matrix metallopeptidase 28 |
| chr1_-_6557441 | 1.17 |
ENST00000400915.3
|
PLEKHG5
|
pleckstrin homology domain containing, family G (with RhoGef domain) member 5 |
| chr7_+_143013198 | 1.17 |
ENST00000343257.2
|
CLCN1
|
chloride channel, voltage-sensitive 1 |
| chr18_-_31628558 | 1.16 |
ENST00000535384.1
|
NOL4
|
nucleolar protein 4 |
| chr17_+_6544078 | 1.16 |
ENST00000250101.5
|
TXNDC17
|
thioredoxin domain containing 17 |
| chr22_-_30685596 | 1.16 |
ENST00000404953.3
ENST00000407689.3 |
GATSL3
|
GATS protein-like 3 |
| chr17_+_7210852 | 1.16 |
ENST00000576930.1
|
EIF5A
|
eukaryotic translation initiation factor 5A |
| chr11_-_66103867 | 1.15 |
ENST00000424433.2
|
RIN1
|
Ras and Rab interactor 1 |
| chr13_-_25745857 | 1.14 |
ENST00000381853.3
|
AMER2
|
APC membrane recruitment protein 2 |
| chr8_-_143696833 | 1.14 |
ENST00000356613.2
|
ARC
|
activity-regulated cytoskeleton-associated protein |
| chr2_+_37571717 | 1.13 |
ENST00000338415.3
ENST00000404976.1 |
QPCT
|
glutaminyl-peptide cyclotransferase |
| chr14_-_51411194 | 1.13 |
ENST00000544180.2
|
PYGL
|
phosphorylase, glycogen, liver |
| chr1_-_156675368 | 1.13 |
ENST00000368222.3
|
CRABP2
|
cellular retinoic acid binding protein 2 |
| chr10_-_76995675 | 1.12 |
ENST00000469299.1
|
COMTD1
|
catechol-O-methyltransferase domain containing 1 |
| chr9_-_131486367 | 1.12 |
ENST00000372663.4
ENST00000406904.2 ENST00000452105.1 ENST00000372672.2 ENST00000372667.5 |
ZDHHC12
|
zinc finger, DHHC-type containing 12 |
| chr11_-_2162162 | 1.11 |
ENST00000381389.1
|
IGF2
|
insulin-like growth factor 2 (somatomedin A) |
| chr2_+_64681103 | 1.11 |
ENST00000464281.1
|
LGALSL
|
lectin, galactoside-binding-like |
| chr15_-_101084446 | 1.11 |
ENST00000538112.2
ENST00000559639.1 ENST00000558884.2 |
CERS3
|
ceramide synthase 3 |
| chr14_-_35183886 | 1.10 |
ENST00000298159.6
|
CFL2
|
cofilin 2 (muscle) |
| chr7_+_147830776 | 1.10 |
ENST00000538075.1
|
CNTNAP2
|
contactin associated protein-like 2 |
| chr2_-_85636928 | 1.10 |
ENST00000449030.1
|
CAPG
|
capping protein (actin filament), gelsolin-like |
| chr2_-_96781984 | 1.09 |
ENST00000409345.3
|
ADRA2B
|
adrenoceptor alpha 2B |
| chr8_-_125740730 | 1.09 |
ENST00000354184.4
|
MTSS1
|
metastasis suppressor 1 |
| chr2_+_37571845 | 1.09 |
ENST00000537448.1
|
QPCT
|
glutaminyl-peptide cyclotransferase |
| chr13_+_52158610 | 1.09 |
ENST00000298125.5
|
WDFY2
|
WD repeat and FYVE domain containing 2 |
| chr12_-_85306594 | 1.09 |
ENST00000266682.5
|
SLC6A15
|
solute carrier family 6 (neutral amino acid transporter), member 15 |
| chr16_-_55866997 | 1.09 |
ENST00000360526.3
ENST00000361503.4 |
CES1
|
carboxylesterase 1 |
| chr19_-_51523412 | 1.08 |
ENST00000391805.1
ENST00000599077.1 |
KLK10
|
kallikrein-related peptidase 10 |
| chr22_-_20255212 | 1.08 |
ENST00000416372.1
|
RTN4R
|
reticulon 4 receptor |
| chr18_-_31803169 | 1.08 |
ENST00000590712.1
|
NOL4
|
nucleolar protein 4 |
| chr17_-_7297519 | 1.07 |
ENST00000576362.1
ENST00000571078.1 |
TMEM256-PLSCR3
|
TMEM256-PLSCR3 readthrough (NMD candidate) |
| chr17_-_34502410 | 1.07 |
ENST00000398801.3
|
TBC1D3B
|
TBC1 domain family, member 3B |
| chr14_-_94421923 | 1.07 |
ENST00000555507.1
|
ASB2
|
ankyrin repeat and SOCS box containing 2 |
| chr12_+_6493319 | 1.07 |
ENST00000536876.1
|
LTBR
|
lymphotoxin beta receptor (TNFR superfamily, member 3) |
| chr20_-_1306351 | 1.07 |
ENST00000381812.1
|
SDCBP2
|
syndecan binding protein (syntenin) 2 |
| chr1_+_155178518 | 1.07 |
ENST00000316721.4
|
MTX1
|
metaxin 1 |
| chr12_+_53443963 | 1.07 |
ENST00000546602.1
ENST00000552570.1 ENST00000549700.1 |
TENC1
|
tensin like C1 domain containing phosphatase (tensin 2) |
| chr18_+_21269556 | 1.07 |
ENST00000399516.3
|
LAMA3
|
laminin, alpha 3 |
| chr15_-_101084547 | 1.07 |
ENST00000394113.1
|
CERS3
|
ceramide synthase 3 |
| chr2_+_85811525 | 1.07 |
ENST00000306384.4
|
VAMP5
|
vesicle-associated membrane protein 5 |
| chr2_+_69001913 | 1.06 |
ENST00000409030.3
ENST00000409220.1 |
ARHGAP25
|
Rho GTPase activating protein 25 |
| chr10_-_76995769 | 1.06 |
ENST00000372538.3
|
COMTD1
|
catechol-O-methyltransferase domain containing 1 |
| chr1_+_155006300 | 1.05 |
ENST00000295542.1
ENST00000392480.1 ENST00000423025.2 ENST00000368419.2 |
DCST1
|
DC-STAMP domain containing 1 |
| chr6_+_47666275 | 1.05 |
ENST00000327753.3
ENST00000283303.2 |
GPR115
|
G protein-coupled receptor 115 |
| chr1_+_24645865 | 1.05 |
ENST00000342072.4
|
GRHL3
|
grainyhead-like 3 (Drosophila) |
| chr20_-_56284816 | 1.04 |
ENST00000395819.3
ENST00000341744.3 |
PMEPA1
|
prostate transmembrane protein, androgen induced 1 |
| chr3_-_127541194 | 1.04 |
ENST00000453507.2
|
MGLL
|
monoglyceride lipase |
Network of associatons between targets according to the STRING database.
First level regulatory network of HIC2
Gene Ontology Analysis
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.4 | 8.4 | GO:0002760 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antimicrobial humoral response(GO:0002760) positive regulation of antibacterial peptide production(GO:0002803) |
| 1.0 | 3.0 | GO:0018262 | isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine(GO:0018153) isopeptide cross-linking(GO:0018262) |
| 1.0 | 2.9 | GO:0097187 | dentinogenesis(GO:0097187) |
| 0.9 | 2.7 | GO:0018199 | peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase(GO:0017186) peptidyl-glutamine modification(GO:0018199) |
| 0.9 | 2.6 | GO:1900085 | negative regulation of peptidyl-tyrosine autophosphorylation(GO:1900085) negative regulation of inward rectifier potassium channel activity(GO:1903609) |
| 0.8 | 2.4 | GO:0000412 | histone peptidyl-prolyl isomerization(GO:0000412) |
| 0.7 | 2.0 | GO:0019858 | cytosine metabolic process(GO:0019858) |
| 0.7 | 2.6 | GO:0090119 | vesicle-mediated cholesterol transport(GO:0090119) |
| 0.6 | 0.6 | GO:0045839 | negative regulation of mitotic nuclear division(GO:0045839) |
| 0.6 | 1.9 | GO:0046103 | adenosine catabolic process(GO:0006154) inosine biosynthetic process(GO:0046103) |
| 0.6 | 1.9 | GO:1900195 | spindle assembly involved in female meiosis I(GO:0007057) positive regulation of oocyte maturation(GO:1900195) |
| 0.6 | 3.1 | GO:0009439 | cyanate metabolic process(GO:0009439) cyanate catabolic process(GO:0009440) |
| 0.6 | 1.8 | GO:0006427 | histidyl-tRNA aminoacylation(GO:0006427) |
| 0.6 | 2.4 | GO:1904647 | response to rotenone(GO:1904647) |
| 0.6 | 1.8 | GO:0032499 | positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002582) positive regulation of antigen processing and presentation of peptide antigen(GO:0002585) positive regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002588) detection of peptidoglycan(GO:0032499) |
| 0.6 | 5.4 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
| 0.6 | 2.3 | GO:2001287 | negative regulation of caveolin-mediated endocytosis(GO:2001287) |
| 0.6 | 2.9 | GO:0036414 | protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
| 0.6 | 2.3 | GO:0042418 | epinephrine biosynthetic process(GO:0042418) |
| 0.6 | 8.5 | GO:0035878 | nail development(GO:0035878) |
| 0.6 | 2.2 | GO:0006668 | sphinganine-1-phosphate metabolic process(GO:0006668) |
| 0.6 | 6.1 | GO:0060753 | regulation of mast cell chemotaxis(GO:0060753) |
| 0.5 | 1.6 | GO:0072186 | metanephric cap development(GO:0072185) metanephric cap morphogenesis(GO:0072186) metanephric cap mesenchymal cell proliferation involved in metanephros development(GO:0090094) |
| 0.5 | 2.7 | GO:0071603 | endothelial cell-cell adhesion(GO:0071603) |
| 0.5 | 1.6 | GO:0019072 | viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
| 0.5 | 1.6 | GO:0044209 | AMP salvage(GO:0044209) |
| 0.5 | 1.5 | GO:0042700 | luteinizing hormone signaling pathway(GO:0042700) |
| 0.5 | 2.0 | GO:0016095 | polyprenol catabolic process(GO:0016095) |
| 0.5 | 1.5 | GO:0019364 | NADP catabolic process(GO:0006742) pyridine nucleotide catabolic process(GO:0019364) |
| 0.5 | 2.5 | GO:0051541 | elastin metabolic process(GO:0051541) |
| 0.5 | 1.5 | GO:1903966 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
| 0.5 | 1.4 | GO:0071109 | superior temporal gyrus development(GO:0071109) |
| 0.5 | 2.4 | GO:0035610 | protein side chain deglutamylation(GO:0035610) |
| 0.5 | 2.4 | GO:0061143 | alveolar primary septum development(GO:0061143) |
| 0.5 | 1.4 | GO:0019242 | methylglyoxal biosynthetic process(GO:0019242) |
| 0.5 | 0.9 | GO:0010728 | regulation of hydrogen peroxide biosynthetic process(GO:0010728) |
| 0.5 | 2.3 | GO:0021553 | olfactory nerve development(GO:0021553) |
| 0.5 | 1.8 | GO:0038195 | urokinase plasminogen activator signaling pathway(GO:0038195) |
| 0.4 | 2.2 | GO:0061107 | seminal vesicle development(GO:0061107) |
| 0.4 | 3.4 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
| 0.4 | 2.5 | GO:0030035 | microspike assembly(GO:0030035) |
| 0.4 | 0.8 | GO:0042310 | vasoconstriction(GO:0042310) |
| 0.4 | 1.7 | GO:1903984 | positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
| 0.4 | 2.5 | GO:0097070 | ductus arteriosus closure(GO:0097070) |
| 0.4 | 1.2 | GO:0006478 | peptidyl-tyrosine sulfation(GO:0006478) |
| 0.4 | 2.0 | GO:0002317 | plasma cell differentiation(GO:0002317) |
| 0.4 | 0.8 | GO:0009409 | response to cold(GO:0009409) |
| 0.4 | 2.7 | GO:0060480 | lung goblet cell differentiation(GO:0060480) |
| 0.4 | 0.8 | GO:0010165 | response to X-ray(GO:0010165) |
| 0.4 | 0.4 | GO:0009946 | proximal/distal axis specification(GO:0009946) |
| 0.4 | 1.9 | GO:0038189 | vestibulocochlear nerve structural organization(GO:0021649) neuropilin signaling pathway(GO:0038189) VEGF-activated neuropilin signaling pathway(GO:0038190) positive regulation of cytokine activity(GO:0060301) ganglion morphogenesis(GO:0061552) positive regulation of retinal ganglion cell axon guidance(GO:1902336) VEGF-activated neuropilin signaling pathway involved in axon guidance(GO:1902378) dorsal root ganglion morphogenesis(GO:1904835) otic placode development(GO:1905040) |
| 0.4 | 0.4 | GO:0008366 | ensheathment of neurons(GO:0007272) axon ensheathment(GO:0008366) |
| 0.4 | 1.4 | GO:0035625 | negative regulation of epinephrine secretion(GO:0032811) epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway(GO:0035625) |
| 0.4 | 1.4 | GO:1990169 | detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
| 0.3 | 0.3 | GO:2000866 | positive regulation of estrogen secretion(GO:2000863) positive regulation of estradiol secretion(GO:2000866) |
| 0.3 | 1.0 | GO:0035624 | receptor transactivation(GO:0035624) |
| 0.3 | 2.0 | GO:0035995 | detection of muscle stretch(GO:0035995) |
| 0.3 | 6.0 | GO:1901750 | leukotriene D4 metabolic process(GO:1901748) leukotriene D4 biosynthetic process(GO:1901750) |
| 0.3 | 1.7 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
| 0.3 | 1.6 | GO:0036324 | vascular endothelial growth factor receptor-2 signaling pathway(GO:0036324) |
| 0.3 | 1.0 | GO:1901350 | cell-cell signaling involved in cell-cell junction organization(GO:1901350) |
| 0.3 | 1.0 | GO:1901301 | regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
| 0.3 | 1.9 | GO:0052565 | response to defense-related nitric oxide production by other organism involved in symbiotic interaction(GO:0052551) response to defense-related host nitric oxide production(GO:0052565) |
| 0.3 | 0.6 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
| 0.3 | 1.9 | GO:0016479 | negative regulation of transcription from RNA polymerase I promoter(GO:0016479) |
| 0.3 | 0.9 | GO:0034970 | histone H3-R2 methylation(GO:0034970) |
| 0.3 | 1.6 | GO:2000969 | positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
| 0.3 | 3.6 | GO:0098887 | neurotransmitter receptor transport, endosome to postsynaptic membrane(GO:0098887) |
| 0.3 | 1.5 | GO:1900425 | negative regulation of defense response to bacterium(GO:1900425) |
| 0.3 | 1.8 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
| 0.3 | 6.6 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
| 0.3 | 0.9 | GO:1903070 | negative regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903070) |
| 0.3 | 0.9 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
| 0.3 | 2.6 | GO:0030043 | actin filament fragmentation(GO:0030043) |
| 0.3 | 2.3 | GO:0002326 | B cell lineage commitment(GO:0002326) |
| 0.3 | 0.9 | GO:0042369 | vitamin D catabolic process(GO:0042369) |
| 0.3 | 1.1 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
| 0.3 | 2.2 | GO:0006452 | translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
| 0.3 | 1.7 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
| 0.3 | 1.9 | GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway(GO:2000323) |
| 0.3 | 1.9 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
| 0.3 | 0.8 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
| 0.3 | 1.8 | GO:2000124 | regulation of endocannabinoid signaling pathway(GO:2000124) |
| 0.3 | 2.1 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
| 0.3 | 0.8 | GO:0045404 | positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
| 0.3 | 3.5 | GO:0015816 | glycine transport(GO:0015816) |
| 0.2 | 0.7 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
| 0.2 | 1.0 | GO:0090107 | regulation of high-density lipoprotein particle assembly(GO:0090107) |
| 0.2 | 0.5 | GO:1902080 | regulation of calcium ion import into sarcoplasmic reticulum(GO:1902080) negative regulation of calcium ion import into sarcoplasmic reticulum(GO:1902081) |
| 0.2 | 1.0 | GO:0010900 | negative regulation of phosphatidylcholine catabolic process(GO:0010900) |
| 0.2 | 1.2 | GO:2001106 | regulation of Rho guanyl-nucleotide exchange factor activity(GO:2001106) |
| 0.2 | 1.0 | GO:0031052 | mesodermal-endodermal cell signaling(GO:0003131) programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) histone H2A-S139 phosphorylation(GO:0035978) positive regulation of cellular response to X-ray(GO:2000685) |
| 0.2 | 0.7 | GO:0021849 | neuroblast division in subventricular zone(GO:0021849) |
| 0.2 | 1.7 | GO:0035965 | cardiolipin acyl-chain remodeling(GO:0035965) |
| 0.2 | 1.0 | GO:0021812 | neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
| 0.2 | 0.2 | GO:0043585 | nose morphogenesis(GO:0043585) |
| 0.2 | 1.2 | GO:0032487 | regulation of Rap protein signal transduction(GO:0032487) |
| 0.2 | 0.7 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
| 0.2 | 0.7 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
| 0.2 | 3.3 | GO:0019885 | antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
| 0.2 | 1.6 | GO:0019264 | glycine biosynthetic process from serine(GO:0019264) |
| 0.2 | 2.7 | GO:1902951 | negative regulation of dendritic spine maintenance(GO:1902951) |
| 0.2 | 0.7 | GO:0089709 | histidine transport(GO:0015817) L-histidine transmembrane transport(GO:0089709) L-histidine transport(GO:1902024) |
| 0.2 | 1.4 | GO:0072675 | multinuclear osteoclast differentiation(GO:0072674) osteoclast fusion(GO:0072675) |
| 0.2 | 0.9 | GO:0097368 | establishment of Sertoli cell barrier(GO:0097368) |
| 0.2 | 2.0 | GO:0048752 | semicircular canal morphogenesis(GO:0048752) |
| 0.2 | 1.3 | GO:0038096 | Fc receptor mediated stimulatory signaling pathway(GO:0002431) immune response-regulating cell surface receptor signaling pathway involved in phagocytosis(GO:0002433) Fc-gamma receptor signaling pathway involved in phagocytosis(GO:0038096) |
| 0.2 | 0.6 | GO:0038098 | sequestering of BMP from receptor via BMP binding(GO:0038098) |
| 0.2 | 0.2 | GO:0090212 | regulation of establishment of blood-brain barrier(GO:0090210) negative regulation of establishment of blood-brain barrier(GO:0090212) |
| 0.2 | 0.4 | GO:0014034 | neural crest cell fate commitment(GO:0014034) |
| 0.2 | 1.0 | GO:0072233 | thick ascending limb development(GO:0072023) metanephric thick ascending limb development(GO:0072233) |
| 0.2 | 0.6 | GO:1905154 | negative regulation of membrane invagination(GO:1905154) |
| 0.2 | 1.9 | GO:2000660 | negative regulation of interleukin-1-mediated signaling pathway(GO:2000660) |
| 0.2 | 4.3 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
| 0.2 | 0.8 | GO:0009257 | 10-formyltetrahydrofolate biosynthetic process(GO:0009257) |
| 0.2 | 0.2 | GO:0016539 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
| 0.2 | 1.6 | GO:0010767 | regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage(GO:0010767) |
| 0.2 | 2.8 | GO:0060019 | radial glial cell differentiation(GO:0060019) |
| 0.2 | 0.8 | GO:1901895 | negative regulation of calcium-transporting ATPase activity(GO:1901895) |
| 0.2 | 0.6 | GO:0046947 | hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
| 0.2 | 0.2 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
| 0.2 | 1.0 | GO:0090131 | mesenchyme migration(GO:0090131) |
| 0.2 | 1.4 | GO:2000669 | positive regulation of pinocytosis(GO:0048549) negative regulation of dendritic cell apoptotic process(GO:2000669) |
| 0.2 | 0.6 | GO:1904640 | response to methionine(GO:1904640) |
| 0.2 | 0.8 | GO:0036116 | medium-chain fatty-acyl-CoA catabolic process(GO:0036114) long-chain fatty-acyl-CoA catabolic process(GO:0036116) palmitic acid metabolic process(GO:1900533) palmitic acid biosynthetic process(GO:1900535) |
| 0.2 | 0.6 | GO:0014062 | regulation of serotonin secretion(GO:0014062) negative regulation of serotonin secretion(GO:0014063) |
| 0.2 | 0.4 | GO:0045994 | positive regulation of translational initiation by iron(GO:0045994) |
| 0.2 | 0.6 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
| 0.2 | 5.6 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
| 0.2 | 0.4 | GO:0097325 | melanocyte proliferation(GO:0097325) |
| 0.2 | 2.3 | GO:0045741 | positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
| 0.2 | 0.8 | GO:0071224 | cellular response to peptidoglycan(GO:0071224) |
| 0.2 | 0.6 | GO:0060364 | induction by symbiont of host defense response(GO:0044416) induction of host immune response by virus(GO:0046730) active induction of host immune response by virus(GO:0046732) modulation by symbiont of host defense response(GO:0052031) induction by organism of defense response of other organism involved in symbiotic interaction(GO:0052251) modulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052255) positive regulation by symbiont of host defense response(GO:0052509) positive regulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052510) modulation by organism of immune response of other organism involved in symbiotic interaction(GO:0052552) modulation by symbiont of host immune response(GO:0052553) frontal suture morphogenesis(GO:0060364) modulation by virus of host immune response(GO:0075528) negative regulation of hyaluronan biosynthetic process(GO:1900126) |
| 0.2 | 2.4 | GO:0014041 | regulation of neuron maturation(GO:0014041) |
| 0.2 | 0.7 | GO:0070901 | mitochondrial tRNA methylation(GO:0070901) |
| 0.2 | 0.9 | GO:0050968 | detection of chemical stimulus involved in sensory perception of pain(GO:0050968) |
| 0.2 | 0.5 | GO:0015770 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
| 0.2 | 0.5 | GO:0072061 | inner medullary collecting duct development(GO:0072061) |
| 0.2 | 1.5 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
| 0.2 | 1.1 | GO:0015824 | proline transport(GO:0015824) proline transmembrane transport(GO:0035524) |
| 0.2 | 0.7 | GO:0007198 | adenylate cyclase-inhibiting serotonin receptor signaling pathway(GO:0007198) |
| 0.2 | 3.1 | GO:0090179 | regulation of establishment of planar polarity involved in neural tube closure(GO:0090178) planar cell polarity pathway involved in neural tube closure(GO:0090179) |
| 0.2 | 2.5 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
| 0.2 | 0.9 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
| 0.2 | 1.4 | GO:0035093 | spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
| 0.2 | 1.0 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
| 0.2 | 0.7 | GO:0007499 | ectoderm and mesoderm interaction(GO:0007499) |
| 0.2 | 1.0 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
| 0.2 | 0.8 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
| 0.2 | 1.0 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
| 0.2 | 0.7 | GO:2000230 | pancreatic stellate cell proliferation(GO:0072343) regulation of pancreatic stellate cell proliferation(GO:2000229) negative regulation of pancreatic stellate cell proliferation(GO:2000230) |
| 0.2 | 1.0 | GO:0034436 | glycoprotein transport(GO:0034436) |
| 0.2 | 2.3 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
| 0.2 | 1.0 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
| 0.2 | 1.4 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
| 0.2 | 0.8 | GO:0000066 | mitochondrial ornithine transport(GO:0000066) |
| 0.2 | 0.5 | GO:0050760 | negative regulation of thymidylate synthase biosynthetic process(GO:0050760) |
| 0.2 | 2.7 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
| 0.2 | 0.9 | GO:0038172 | interleukin-33-mediated signaling pathway(GO:0038172) |
| 0.2 | 1.7 | GO:0046886 | positive regulation of hormone biosynthetic process(GO:0046886) |
| 0.2 | 3.0 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
| 0.2 | 0.5 | GO:0036484 | trunk segmentation(GO:0035290) trunk neural crest cell migration(GO:0036484) ventral trunk neural crest cell migration(GO:0036486) |
| 0.2 | 0.8 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
| 0.1 | 1.0 | GO:0006642 | triglyceride mobilization(GO:0006642) |
| 0.1 | 0.3 | GO:0010593 | negative regulation of lamellipodium assembly(GO:0010593) |
| 0.1 | 0.9 | GO:0055064 | chloride ion homeostasis(GO:0055064) |
| 0.1 | 3.1 | GO:0043651 | linoleic acid metabolic process(GO:0043651) |
| 0.1 | 0.3 | GO:0033861 | negative regulation of NAD(P)H oxidase activity(GO:0033861) |
| 0.1 | 0.1 | GO:0000960 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
| 0.1 | 1.2 | GO:0030320 | cellular anion homeostasis(GO:0030002) cellular monovalent inorganic anion homeostasis(GO:0030320) cellular phosphate ion homeostasis(GO:0030643) cellular divalent inorganic anion homeostasis(GO:0072501) cellular trivalent inorganic anion homeostasis(GO:0072502) |
| 0.1 | 0.6 | GO:0001808 | negative regulation of type IV hypersensitivity(GO:0001808) |
| 0.1 | 1.2 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
| 0.1 | 0.7 | GO:0035672 | oligopeptide transmembrane transport(GO:0035672) |
| 0.1 | 0.7 | GO:0006015 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
| 0.1 | 1.1 | GO:0007506 | gonadal mesoderm development(GO:0007506) |
| 0.1 | 0.8 | GO:0014028 | notochord formation(GO:0014028) |
| 0.1 | 0.3 | GO:0070093 | negative regulation of glucagon secretion(GO:0070093) |
| 0.1 | 1.6 | GO:0032119 | sequestering of zinc ion(GO:0032119) |
| 0.1 | 2.5 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
| 0.1 | 0.7 | GO:0034196 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
| 0.1 | 0.4 | GO:0007206 | phospholipase C-activating G-protein coupled glutamate receptor signaling pathway(GO:0007206) |
| 0.1 | 0.5 | GO:0019249 | lactate biosynthetic process(GO:0019249) |
| 0.1 | 0.4 | GO:0022614 | membrane to membrane docking(GO:0022614) |
| 0.1 | 0.3 | GO:0060584 | regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
| 0.1 | 0.5 | GO:0033563 | dorsal/ventral axon guidance(GO:0033563) |
| 0.1 | 2.0 | GO:0051451 | myoblast migration(GO:0051451) |
| 0.1 | 0.5 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
| 0.1 | 1.8 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
| 0.1 | 0.7 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
| 0.1 | 0.4 | GO:0006422 | aspartyl-tRNA aminoacylation(GO:0006422) |
| 0.1 | 0.5 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
| 0.1 | 0.3 | GO:0060872 | semicircular canal development(GO:0060872) |
| 0.1 | 2.3 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
| 0.1 | 0.3 | GO:0061298 | retina vasculature development in camera-type eye(GO:0061298) |
| 0.1 | 0.4 | GO:0060940 | epithelial to mesenchymal transition involved in cardiac fibroblast development(GO:0060940) |
| 0.1 | 0.1 | GO:0048807 | female genitalia morphogenesis(GO:0048807) |
| 0.1 | 0.4 | GO:0048627 | myoblast development(GO:0048627) |
| 0.1 | 0.4 | GO:0036509 | trimming of terminal mannose on B branch(GO:0036509) trimming of first mannose on A branch(GO:0036511) trimming of second mannose on A branch(GO:0036512) |
| 0.1 | 0.3 | GO:0045196 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
| 0.1 | 2.0 | GO:0051608 | histamine transport(GO:0051608) |
| 0.1 | 0.5 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
| 0.1 | 1.2 | GO:0001778 | plasma membrane repair(GO:0001778) |
| 0.1 | 2.7 | GO:0070498 | interleukin-1-mediated signaling pathway(GO:0070498) |
| 0.1 | 1.1 | GO:0035634 | response to stilbenoid(GO:0035634) |
| 0.1 | 0.4 | GO:1900220 | semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
| 0.1 | 1.6 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
| 0.1 | 0.2 | GO:0071883 | activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
| 0.1 | 0.6 | GO:0030070 | insulin processing(GO:0030070) |
| 0.1 | 1.6 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
| 0.1 | 3.0 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
| 0.1 | 0.7 | GO:0006789 | bilirubin conjugation(GO:0006789) |
| 0.1 | 0.7 | GO:0043587 | tongue morphogenesis(GO:0043587) |
| 0.1 | 0.6 | GO:0019470 | 4-hydroxyproline catabolic process(GO:0019470) |
| 0.1 | 0.1 | GO:0090303 | positive regulation of wound healing(GO:0090303) |
| 0.1 | 0.6 | GO:0042631 | cellular response to water deprivation(GO:0042631) |
| 0.1 | 0.5 | GO:1902460 | regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
| 0.1 | 0.5 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
| 0.1 | 0.3 | GO:0003383 | apical constriction(GO:0003383) |
| 0.1 | 0.9 | GO:0021936 | regulation of cerebellar granule cell precursor proliferation(GO:0021936) |
| 0.1 | 1.3 | GO:0008343 | adult feeding behavior(GO:0008343) |
| 0.1 | 0.5 | GO:0007538 | primary sex determination(GO:0007538) |
| 0.1 | 3.5 | GO:0007398 | ectoderm development(GO:0007398) |
| 0.1 | 0.4 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
| 0.1 | 0.7 | GO:0006939 | smooth muscle contraction(GO:0006939) |
| 0.1 | 0.6 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
| 0.1 | 1.1 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
| 0.1 | 0.3 | GO:0034971 | histone H3-R17 methylation(GO:0034971) |
| 0.1 | 0.3 | GO:0003430 | growth plate cartilage chondrocyte growth(GO:0003430) |
| 0.1 | 4.4 | GO:0050919 | negative chemotaxis(GO:0050919) |
| 0.1 | 1.9 | GO:0097264 | self proteolysis(GO:0097264) |
| 0.1 | 0.5 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
| 0.1 | 0.3 | GO:0048213 | Golgi vesicle prefusion complex stabilization(GO:0048213) |
| 0.1 | 0.8 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
| 0.1 | 0.2 | GO:0030860 | regulation of polarized epithelial cell differentiation(GO:0030860) |
| 0.1 | 0.5 | GO:0070458 | cellular detoxification of nitrogen compound(GO:0070458) |
| 0.1 | 0.1 | GO:0008078 | mesodermal cell migration(GO:0008078) |
| 0.1 | 0.3 | GO:0070460 | thyroid-stimulating hormone secretion(GO:0070460) regulation of thyroid-stimulating hormone secretion(GO:2000612) |
| 0.1 | 5.4 | GO:0043001 | Golgi to plasma membrane protein transport(GO:0043001) |
| 0.1 | 0.2 | GO:0039019 | pronephric nephron development(GO:0039019) |
| 0.1 | 0.6 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
| 0.1 | 1.6 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
| 0.1 | 0.9 | GO:0045656 | negative regulation of monocyte differentiation(GO:0045656) |
| 0.1 | 1.1 | GO:0006777 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) |
| 0.1 | 0.3 | GO:0021503 | neural fold bending(GO:0021503) |
| 0.1 | 0.9 | GO:0032596 | protein transport into membrane raft(GO:0032596) |
| 0.1 | 0.3 | GO:0035790 | platelet-derived growth factor receptor-alpha signaling pathway(GO:0035790) |
| 0.1 | 0.9 | GO:0016199 | axon midline choice point recognition(GO:0016199) |
| 0.1 | 0.4 | GO:0061299 | retina vasculature morphogenesis in camera-type eye(GO:0061299) |
| 0.1 | 1.5 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
| 0.1 | 0.2 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
| 0.1 | 0.6 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
| 0.1 | 1.1 | GO:0098870 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
| 0.1 | 0.3 | GO:0018011 | N-terminal protein amino acid methylation(GO:0006480) N-terminal peptidyl-alanine methylation(GO:0018011) N-terminal peptidyl-alanine trimethylation(GO:0018012) N-terminal peptidyl-glycine methylation(GO:0018013) N-terminal peptidyl-proline dimethylation(GO:0018016) peptidyl-alanine modification(GO:0018194) N-terminal peptidyl-proline methylation(GO:0035568) N-terminal peptidyl-serine methylation(GO:0035570) N-terminal peptidyl-serine dimethylation(GO:0035572) N-terminal peptidyl-serine trimethylation(GO:0035573) |
| 0.1 | 0.2 | GO:2001171 | positive regulation of ATP biosynthetic process(GO:2001171) |
| 0.1 | 0.4 | GO:1903566 | positive regulation of protein localization to cilium(GO:1903566) |
| 0.1 | 0.1 | GO:0038129 | ERBB3 signaling pathway(GO:0038129) |
| 0.1 | 0.1 | GO:0015920 | lipopolysaccharide transport(GO:0015920) |
| 0.1 | 1.3 | GO:0070327 | thyroid hormone transport(GO:0070327) |
| 0.1 | 0.3 | GO:0023019 | signal transduction involved in regulation of gene expression(GO:0023019) |
| 0.1 | 0.3 | GO:0006500 | N-terminal protein palmitoylation(GO:0006500) |
| 0.1 | 0.3 | GO:0072081 | proximal/distal pattern formation involved in nephron development(GO:0072047) specification of nephron tubule identity(GO:0072081) specification of loop of Henle identity(GO:0072086) pattern specification involved in metanephros development(GO:0072268) |
| 0.1 | 0.5 | GO:0038170 | somatostatin receptor signaling pathway(GO:0038169) somatostatin signaling pathway(GO:0038170) |
| 0.1 | 0.9 | GO:1901525 | negative regulation of macromitophagy(GO:1901525) |
| 0.1 | 1.3 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
| 0.1 | 1.4 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
| 0.1 | 0.4 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) |
| 0.1 | 0.3 | GO:0071922 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
| 0.1 | 3.3 | GO:0035767 | endothelial cell chemotaxis(GO:0035767) |
| 0.1 | 0.6 | GO:0009082 | branched-chain amino acid biosynthetic process(GO:0009082) leucine biosynthetic process(GO:0009098) valine biosynthetic process(GO:0009099) |
| 0.1 | 0.3 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
| 0.1 | 0.5 | GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) positive regulation of blood vessel remodeling(GO:2000504) |
| 0.1 | 0.7 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
| 0.1 | 0.7 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
| 0.1 | 1.7 | GO:0007021 | tubulin complex assembly(GO:0007021) |
| 0.1 | 0.9 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
| 0.1 | 0.3 | GO:2001045 | closure of optic fissure(GO:0061386) negative regulation of integrin-mediated signaling pathway(GO:2001045) |
| 0.1 | 0.4 | GO:0071469 | detection of mechanical stimulus involved in sensory perception of touch(GO:0050976) cellular response to alkaline pH(GO:0071469) |
| 0.1 | 0.5 | GO:0070995 | NADPH oxidation(GO:0070995) |
| 0.1 | 0.1 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
| 0.1 | 0.4 | GO:1904180 | negative regulation of mitochondrial depolarization(GO:0051902) negative regulation of membrane depolarization(GO:1904180) |
| 0.1 | 0.5 | GO:0031017 | exocrine pancreas development(GO:0031017) |
| 0.1 | 0.5 | GO:0042816 | vitamin B6 metabolic process(GO:0042816) |
| 0.1 | 0.3 | GO:1903146 | regulation of mitophagy(GO:1903146) |
| 0.1 | 2.5 | GO:0006491 | N-glycan processing(GO:0006491) |
| 0.1 | 1.9 | GO:0001946 | lymphangiogenesis(GO:0001946) |
| 0.1 | 0.1 | GO:0097695 | establishment of RNA localization to telomere(GO:0097694) establishment of macromolecular complex localization to telomere(GO:0097695) negative regulation of protein localization to chromosome, telomeric region(GO:1904815) |
| 0.1 | 0.7 | GO:0060573 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
| 0.1 | 0.3 | GO:0030187 | melatonin metabolic process(GO:0030186) melatonin biosynthetic process(GO:0030187) |
| 0.1 | 0.4 | GO:0061767 | negative regulation of lung blood pressure(GO:0061767) |
| 0.1 | 0.6 | GO:0035855 | megakaryocyte development(GO:0035855) |
| 0.1 | 5.1 | GO:0045540 | regulation of cholesterol biosynthetic process(GO:0045540) |
| 0.1 | 0.3 | GO:0019442 | tryptophan catabolic process to acetyl-CoA(GO:0019442) |
| 0.1 | 1.0 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
| 0.1 | 0.5 | GO:0032185 | septin cytoskeleton organization(GO:0032185) |
| 0.1 | 0.3 | GO:0086097 | phospholipase C-activating angiotensin-activated signaling pathway(GO:0086097) |
| 0.1 | 0.9 | GO:0097398 | response to interleukin-17(GO:0097396) cellular response to interleukin-17(GO:0097398) |
| 0.1 | 0.3 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
| 0.1 | 0.7 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
| 0.1 | 0.9 | GO:0007162 | negative regulation of cell adhesion(GO:0007162) |
| 0.1 | 0.7 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
| 0.1 | 0.4 | GO:0071802 | negative regulation of podosome assembly(GO:0071802) |
| 0.1 | 0.5 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
| 0.1 | 1.0 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
| 0.1 | 0.4 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
| 0.1 | 0.4 | GO:0055014 | atrial cardiac muscle cell differentiation(GO:0055011) atrial cardiac muscle cell development(GO:0055014) |
| 0.1 | 0.5 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
| 0.1 | 1.3 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
| 0.1 | 0.2 | GO:0003285 | septum secundum development(GO:0003285) |
| 0.1 | 1.2 | GO:0035090 | maintenance of apical/basal cell polarity(GO:0035090) maintenance of epithelial cell apical/basal polarity(GO:0045199) |
| 0.1 | 0.2 | GO:0042321 | negative regulation of circadian sleep/wake cycle, sleep(GO:0042321) |
| 0.1 | 0.7 | GO:0043615 | astrocyte cell migration(GO:0043615) |
| 0.1 | 1.3 | GO:0000338 | protein deneddylation(GO:0000338) |
| 0.1 | 2.4 | GO:0015804 | neutral amino acid transport(GO:0015804) |
| 0.1 | 0.3 | GO:0071279 | cellular response to cobalt ion(GO:0071279) |
| 0.1 | 0.8 | GO:2001135 | regulation of endocytic recycling(GO:2001135) |
| 0.1 | 0.5 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
| 0.1 | 0.6 | GO:0072584 | caveolin-mediated endocytosis(GO:0072584) |
| 0.1 | 9.1 | GO:0070268 | cornification(GO:0070268) |
| 0.1 | 1.0 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
| 0.1 | 0.1 | GO:0016115 | terpenoid catabolic process(GO:0016115) |
| 0.1 | 1.7 | GO:0097320 | membrane tubulation(GO:0097320) |
| 0.1 | 0.4 | GO:0002024 | diet induced thermogenesis(GO:0002024) |
| 0.1 | 0.4 | GO:0003322 | pancreatic A cell development(GO:0003322) |
| 0.1 | 0.8 | GO:0045217 | cell-cell junction maintenance(GO:0045217) |
| 0.1 | 1.5 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
| 0.1 | 0.4 | GO:0060017 | parathyroid gland development(GO:0060017) |
| 0.1 | 0.8 | GO:0071374 | cellular response to parathyroid hormone stimulus(GO:0071374) |
| 0.1 | 0.5 | GO:0019511 | peptidyl-proline hydroxylation(GO:0019511) |
| 0.1 | 0.4 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
| 0.1 | 0.5 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
| 0.1 | 0.3 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
| 0.1 | 0.3 | GO:0000103 | sulfate assimilation(GO:0000103) |
| 0.1 | 0.2 | GO:1900060 | negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) negative regulation of ceramide biosynthetic process(GO:1900060) |
| 0.1 | 1.0 | GO:0071318 | cellular response to ATP(GO:0071318) |
| 0.1 | 0.3 | GO:0033274 | response to vitamin B2(GO:0033274) heterochromatin maintenance(GO:0070829) |
| 0.1 | 0.2 | GO:0045110 | neurofilament bundle assembly(GO:0033693) intermediate filament bundle assembly(GO:0045110) |
| 0.1 | 0.5 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
| 0.1 | 3.3 | GO:1901385 | regulation of voltage-gated calcium channel activity(GO:1901385) |
| 0.1 | 0.2 | GO:1990523 | bone regeneration(GO:1990523) |
| 0.1 | 1.4 | GO:0034587 | piRNA metabolic process(GO:0034587) |
| 0.1 | 0.2 | GO:1903625 | negative regulation of DNA catabolic process(GO:1903625) |
| 0.1 | 3.3 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
| 0.1 | 0.5 | GO:0021559 | zygotic determination of anterior/posterior axis, embryo(GO:0007354) thorax and anterior abdomen determination(GO:0007356) trigeminal nerve development(GO:0021559) |
| 0.1 | 0.6 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
| 0.1 | 0.8 | GO:0060856 | establishment of blood-brain barrier(GO:0060856) |
| 0.1 | 0.2 | GO:0071301 | transcription factor catabolic process(GO:0036369) cellular response to vitamin B1(GO:0071301) response to formaldehyde(GO:1904404) |
| 0.1 | 0.8 | GO:0060346 | bone trabecula formation(GO:0060346) bone trabecula morphogenesis(GO:0061430) |
| 0.1 | 0.8 | GO:0045078 | positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
| 0.1 | 0.9 | GO:0042420 | dopamine catabolic process(GO:0042420) |
| 0.1 | 0.2 | GO:0051970 | negative regulation of transmission of nerve impulse(GO:0051970) |
| 0.1 | 1.0 | GO:0071459 | protein localization to chromosome, centromeric region(GO:0071459) |
| 0.1 | 0.2 | GO:0031456 | glycine betaine biosynthetic process from choline(GO:0019285) glycine betaine metabolic process(GO:0031455) glycine betaine biosynthetic process(GO:0031456) |
| 0.1 | 0.4 | GO:0061737 | leukotriene signaling pathway(GO:0061737) |
| 0.1 | 0.2 | GO:0014846 | esophagus smooth muscle contraction(GO:0014846) |
| 0.1 | 0.2 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) |
| 0.1 | 0.2 | GO:0060460 | left lung development(GO:0060459) left lung morphogenesis(GO:0060460) |
| 0.1 | 0.2 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
| 0.1 | 0.7 | GO:0048251 | elastic fiber assembly(GO:0048251) |
| 0.1 | 3.6 | GO:0046579 | positive regulation of Ras protein signal transduction(GO:0046579) |
| 0.1 | 0.6 | GO:0051665 | membrane raft localization(GO:0051665) |
| 0.1 | 0.2 | GO:0048250 | mitochondrial iron ion transport(GO:0048250) |
| 0.1 | 0.8 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
| 0.1 | 0.5 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
| 0.1 | 0.2 | GO:0048631 | regulation of skeletal muscle tissue growth(GO:0048631) |
| 0.1 | 0.6 | GO:0097106 | postsynaptic density organization(GO:0097106) |
| 0.1 | 0.6 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
| 0.1 | 1.2 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
| 0.1 | 0.2 | GO:0060370 | susceptibility to T cell mediated cytotoxicity(GO:0060370) |
| 0.1 | 0.2 | GO:0038163 | thrombopoietin-mediated signaling pathway(GO:0038163) |
| 0.1 | 0.2 | GO:0032417 | positive regulation of sodium:proton antiporter activity(GO:0032417) |
| 0.1 | 0.1 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
| 0.1 | 0.5 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
| 0.1 | 1.1 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
| 0.1 | 0.7 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
| 0.1 | 0.1 | GO:0035928 | rRNA import into mitochondrion(GO:0035928) |
| 0.1 | 1.9 | GO:1903861 | regulation of dendrite extension(GO:1903859) positive regulation of dendrite extension(GO:1903861) |
| 0.1 | 0.9 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
| 0.1 | 0.2 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
| 0.1 | 0.2 | GO:1902766 | skeletal muscle satellite cell migration(GO:1902766) |
| 0.1 | 0.1 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
| 0.1 | 0.4 | GO:2000111 | positive regulation of macrophage apoptotic process(GO:2000111) |
| 0.1 | 0.9 | GO:0071354 | cellular response to interleukin-6(GO:0071354) |
| 0.1 | 0.4 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
| 0.1 | 0.4 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
| 0.1 | 0.3 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
| 0.1 | 0.4 | GO:1990564 | protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
| 0.1 | 0.9 | GO:0075522 | IRES-dependent viral translational initiation(GO:0075522) |
| 0.1 | 0.5 | GO:0034378 | chylomicron assembly(GO:0034378) |
| 0.1 | 0.9 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
| 0.1 | 0.2 | GO:0019413 | acetate biosynthetic process(GO:0019413) acetyl-CoA biosynthetic process from acetate(GO:0019427) propionate metabolic process(GO:0019541) propionate biosynthetic process(GO:0019542) |
| 0.1 | 0.4 | GO:0051496 | positive regulation of stress fiber assembly(GO:0051496) |
| 0.1 | 0.4 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
| 0.1 | 0.5 | GO:0042325 | regulation of phosphorylation(GO:0042325) |
| 0.1 | 0.3 | GO:0006436 | tryptophanyl-tRNA aminoacylation(GO:0006436) |
| 0.1 | 0.2 | GO:0038193 | thromboxane A2 signaling pathway(GO:0038193) |
| 0.1 | 0.1 | GO:0032571 | response to vitamin K(GO:0032571) |
| 0.1 | 0.1 | GO:0072553 | terminal button organization(GO:0072553) |
| 0.1 | 0.9 | GO:0051894 | positive regulation of focal adhesion assembly(GO:0051894) |
| 0.1 | 1.5 | GO:0035728 | response to hepatocyte growth factor(GO:0035728) |
| 0.1 | 0.2 | GO:1902595 | regulation of DNA replication origin binding(GO:1902595) |
| 0.0 | 0.4 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
| 0.0 | 0.4 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
| 0.0 | 0.2 | GO:0061083 | regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) |
| 0.0 | 0.8 | GO:0051014 | actin filament severing(GO:0051014) |
| 0.0 | 0.2 | GO:0038155 | interleukin-23-mediated signaling pathway(GO:0038155) |
| 0.0 | 0.3 | GO:0048245 | eosinophil chemotaxis(GO:0048245) |
| 0.0 | 3.8 | GO:0030574 | collagen catabolic process(GO:0030574) |
| 0.0 | 0.3 | GO:0045586 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
| 0.0 | 0.7 | GO:0050774 | negative regulation of dendrite morphogenesis(GO:0050774) |
| 0.0 | 0.3 | GO:0035865 | cellular response to potassium ion(GO:0035865) |
| 0.0 | 0.3 | GO:0045939 | negative regulation of steroid metabolic process(GO:0045939) |
| 0.0 | 1.3 | GO:0036507 | protein demannosylation(GO:0036507) protein alpha-1,2-demannosylation(GO:0036508) endoplasmic reticulum mannose trimming(GO:1904380) |
| 0.0 | 0.1 | GO:1900153 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900151) positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900153) |
| 0.0 | 0.1 | GO:1902564 | negative regulation of neutrophil activation(GO:1902564) |
| 0.0 | 0.3 | GO:0060215 | primitive hemopoiesis(GO:0060215) |
| 0.0 | 1.9 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
| 0.0 | 0.7 | GO:0002544 | chronic inflammatory response(GO:0002544) |
| 0.0 | 0.2 | GO:0060348 | bone development(GO:0060348) |
| 0.0 | 0.2 | GO:0035811 | negative regulation of urine volume(GO:0035811) |
| 0.0 | 0.4 | GO:0017085 | response to insecticide(GO:0017085) |
| 0.0 | 0.4 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
| 0.0 | 0.3 | GO:0046604 | positive regulation of mitotic centrosome separation(GO:0046604) |
| 0.0 | 0.2 | GO:0090287 | regulation of cellular response to growth factor stimulus(GO:0090287) |
| 0.0 | 0.3 | GO:0060125 | negative regulation of growth hormone secretion(GO:0060125) |
| 0.0 | 0.3 | GO:0052696 | flavonoid glucuronidation(GO:0052696) xenobiotic glucuronidation(GO:0052697) |
| 0.0 | 0.1 | GO:0001694 | histamine biosynthetic process(GO:0001694) |
| 0.0 | 0.2 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
| 0.0 | 1.1 | GO:0007141 | male meiosis I(GO:0007141) |
| 0.0 | 0.5 | GO:0019532 | oxalate transport(GO:0019532) |
| 0.0 | 0.3 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
| 0.0 | 0.2 | GO:0055067 | monovalent inorganic cation homeostasis(GO:0055067) |
| 0.0 | 1.0 | GO:0008053 | mitochondrial fusion(GO:0008053) |
| 0.0 | 0.1 | GO:0005989 | lactose metabolic process(GO:0005988) lactose biosynthetic process(GO:0005989) disaccharide biosynthetic process(GO:0046351) |
| 0.0 | 0.4 | GO:0090394 | negative regulation of excitatory postsynaptic potential(GO:0090394) |
| 0.0 | 0.2 | GO:0001575 | globoside metabolic process(GO:0001575) |
| 0.0 | 0.1 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
| 0.0 | 0.1 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
| 0.0 | 0.6 | GO:0042104 | positive regulation of activated T cell proliferation(GO:0042104) |
| 0.0 | 0.3 | GO:2000465 | regulation of glycogen (starch) synthase activity(GO:2000465) |
| 0.0 | 0.2 | GO:0045667 | regulation of osteoblast differentiation(GO:0045667) |
| 0.0 | 0.5 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
| 0.0 | 0.8 | GO:0030325 | adrenal gland development(GO:0030325) |
| 0.0 | 0.5 | GO:0090520 | sphingosine-1-phosphate signaling pathway(GO:0003376) sphingolipid mediated signaling pathway(GO:0090520) |
| 0.0 | 0.3 | GO:0030889 | negative regulation of B cell proliferation(GO:0030889) |
| 0.0 | 0.8 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
| 0.0 | 0.3 | GO:0007197 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) |
| 0.0 | 0.2 | GO:0043606 | histidine catabolic process to glutamate and formamide(GO:0019556) histidine catabolic process to glutamate and formate(GO:0019557) formamide metabolic process(GO:0043606) |
| 0.0 | 0.2 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
| 0.0 | 0.6 | GO:0050872 | white fat cell differentiation(GO:0050872) |
| 0.0 | 0.4 | GO:0072661 | protein targeting to plasma membrane(GO:0072661) |
| 0.0 | 0.9 | GO:0070262 | peptidyl-serine dephosphorylation(GO:0070262) |
| 0.0 | 1.1 | GO:0051156 | glucose 6-phosphate metabolic process(GO:0051156) |
| 0.0 | 0.6 | GO:0034446 | substrate adhesion-dependent cell spreading(GO:0034446) |
| 0.0 | 0.1 | GO:0032764 | negative regulation of mast cell cytokine production(GO:0032764) negative regulation of isotype switching to IgE isotypes(GO:0048294) |
| 0.0 | 2.9 | GO:0045445 | myoblast differentiation(GO:0045445) |
| 0.0 | 0.0 | GO:0097360 | chorionic trophoblast cell proliferation(GO:0097360) regulation of chorionic trophoblast cell proliferation(GO:1901382) |
| 0.0 | 0.2 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
| 0.0 | 0.3 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
| 0.0 | 0.2 | GO:0051024 | positive regulation of immunoglobulin secretion(GO:0051024) |
| 0.0 | 0.4 | GO:2000344 | positive regulation of acrosome reaction(GO:2000344) |
| 0.0 | 0.5 | GO:2000781 | positive regulation of double-strand break repair(GO:2000781) |
| 0.0 | 0.2 | GO:0071918 |